$4.81
Today
as of Sep 4, 16:55 ET
Last 30 days
Recent Press Releases & News
Treace Medical (TMCI) Q2 2026 Earnings Call Transcript
Truist Securities Adjusts PT on Treace Medical Concepts to $5 From $4, Keeps Hold Rating
Treace Medical Concepts, Inc. Q2 2026 Earnings Call Summary
Overview
52-week range
$1.17
$7.63
56% of range
Avg surprise (last 3)
+10.8%
Avg reaction (last 2)
+4.7%
100% positive
Latest IV / EM
53%
EM ±8.3% · $5 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.24 | — | — | — | — | financials |
| Fri May 8, 2026 | Mar/2026 | $-0.28 | $-0.31 | +9.7% | -12.0% | +4.7% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.26 | — | — | — | — | financials |
| Thu Aug 7, 2025 | Jun/2025 | $-0.28 | $-0.29 | +3.5% | — | — | earnings |
| Thu May 8, 2025 | Mar/2025 | $-0.25 | $-0.31 | +19.4% | — | +4.7% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.25 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.34 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.30 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.28 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.20 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.23 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $45M | $47M | — | $50M | $47M | $53M | — | $45M |
| Cost of revenue | $10M | $10M | — | $11M | $10M | $11M | — | $9M |
| Gross profit | $36M | $37M | — | $40M | $38M | $42M | — | $36M |
| Operating income | $-15M | $-17M | — | $-16M | $-17M | $-16M | — | $-15M |
| Net income | $-16M | $-18M | — | $-16M | $-17M | $-16M | — | $-15M |
| EPS (diluted) | $-0.24 | $-0.28 | — | $-0.26 | $-0.28 | $-0.25 | — | $-0.25 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $13M | $10M | $11M | $8M | $8M | $13M | $11M | $12M |
| Inventory | $40M | $36M | $36M | $41M | $42M | $38M | $39M | $44M |
| Total current assets | $120M | $123M | $132M | $138M | $148M | $149M | $161M | $158M |
| Total assets | $181M | $184M | $191M | $197M | $206M | $206M | $217M | $213M |
| Long-term debt | $56M | $56M | $56M | $54M | $53M | $53M | $53M | $53M |
| Total liabilities | $113M | $107M | $103M | $107M | $109M | $101M | $104M | $108M |
| Total equity | $68M | $77M | $87M | $89M | $98M | $105M | $113M | $105M |